Volition Presents New Liquid Biopsy Method for Early-Stage Cancer
VolitionRx detailed a new liquid biopsy cancer-detection method at the annual congress of the European Society for Medical Oncology.
Read MorePosted by Andy Lundin | Oct 23, 2023 | Cancer, Molecular Diagnostics |
VolitionRx detailed a new liquid biopsy cancer-detection method at the annual congress of the European Society for Medical Oncology.
Read MorePosted by Andy Lundin | Sep 27, 2023 | Immunoassay |
Mission Bio’s Tapestri Single-cell MRD AML Multiomics Assay is designed to bring resolution to disease relapse in acute myeloid leukemia.
Read MorePosted by Andy Lundin | Sep 13, 2023 | Unknown Origin & Other Cancer Types |
The study’s impact is multifaceted, potentially influencing the development of non-invasive diagnostic tests and novel medicines.
Read MorePosted by Andy Lundin | Aug 10, 2023 | Microscopy |
Scientists developed an AI system that recognizes and characterizes white and red blood cells in microscopic images of blood samples.
Read MorePosted by Andy Lundin | Aug 8, 2023 | Unknown Origin & Other Cancer Types |
Blood disorders known as MDS are difficult to diagnose putting patients at increased risk for treatment mistakes from misdiagnosis.
Read More